2006
DOI: 10.1016/j.bpc.2005.12.003
|View full text |Cite
|
Sign up to set email alerts
|

Complexation of norfloxacin with DNA in the presence of caffeine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
26
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(28 citation statements)
references
References 30 publications
2
26
0
Order By: Relevance
“…It has been reported previously that CAF and other MTX form stacking aggregates with aromatic dyes: acridine orange [82][83][84], ethidium bromide [20,81,85], 4 ,6-diamidino-2-phenylindole (DAPI) [81], methylene blue [86], anticancer drugs: doxorubicin, mitoxantrone, and daunomycin [17,24,81,87], antibacterial agent norfloxacin [88], vitamin B 2 derivative flavinmononucleotide [87], neurotoxins [36,89], and aromatic mutagens [22,35]. Some of these reports reveal in vivo effects of observed heterocomplexation, indicating that molecular complex formation between aromatic compounds can be relevant in biological systems [22,35,36,89].…”
Section: Heterocomplexation Of Mtx With Other Aromatic Ligandsmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been reported previously that CAF and other MTX form stacking aggregates with aromatic dyes: acridine orange [82][83][84], ethidium bromide [20,81,85], 4 ,6-diamidino-2-phenylindole (DAPI) [81], methylene blue [86], anticancer drugs: doxorubicin, mitoxantrone, and daunomycin [17,24,81,87], antibacterial agent norfloxacin [88], vitamin B 2 derivative flavinmononucleotide [87], neurotoxins [36,89], and aromatic mutagens [22,35]. Some of these reports reveal in vivo effects of observed heterocomplexation, indicating that molecular complex formation between aromatic compounds can be relevant in biological systems [22,35,36,89].…”
Section: Heterocomplexation Of Mtx With Other Aromatic Ligandsmentioning
confidence: 99%
“…It was demonstrated that CAF and other MTX can inhibit DNA binding or even induce deintercalation of aromatic ligands from DNA [20,21,84,88]. It is still discussed whether this effect results barely from the decrease in ligand availability due to its interception by MTX or can be also contributed to the reduction of binding sites on DNA available for ligands caused by MTX intercalation.…”
Section: Heterocomplexation Of Mtx With Other Aromatic Ligandsmentioning
confidence: 99%
“…A method has been suggested to analyse the 'interceptor' and 'protector' mechanisms simultaneously in recent reports on the CAF-Antibiotic [44,64] and Vitamin-Antibiotic [50] systems. In the present work that analysis is generalised for the group of aromatic molecules, which exert their biological effect via complexation with DNA.…”
Section: Introductionmentioning
confidence: 99%
“…Hetero-association in Drug-xanthine systems has been extensively studied by NMR, UV-vis, Fluorescence spectroscopies, titration microcalorimetry, partitioning in waterorganic mixture, molecular modelling and other techniques for the following aromatic drugs: daunomycin (DAU) [127,[133][134][135][136], doxorubicin (DOX) [33,42,127,[137][138][139], actinomycin D (AMD) and its derivatives [133,[140][141][142][143], benzene and its derivatives [122,144], novantrone/mitoxantrone (NOV) [42, 127, 135-137, 145, 146], nogalamycin (NOG) [138], norfloxacin (NOR) [135,136,147], camptothecins [139,148,149], quinoxaline [84], chloroquine [84], DAPI [150], phenothiazines [121,151,152], riboflavin [135,[153][154][155], porphyrins [156,157], acridine mutagens [53,54,124,125,[133][134]…”
Section: Drug-xanthine Systemmentioning
confidence: 99%